News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
270,660 Results
Type
Article (17182)
Company Profile (33)
Press Release (253443)
Multimedia
Podcasts (17)
Webinars (5)
Section
Business (81471)
Career Advice (581)
Deals (14378)
Drug Delivery (25)
Drug Development (34207)
Employer Resources (40)
FDA (6178)
Job Trends (6258)
News (135103)
Policy (10279)
Tag
Academia (749)
Accelerated approval (5)
Adcomms (5)
Allergies (50)
Alliances (14500)
ALS (57)
Alzheimer's disease (563)
Antibody-drug conjugate (ADC) (64)
Approvals (6298)
Artificial intelligence (170)
Autoimmune disease (26)
Automation (12)
Bankruptcy (116)
Best Places to Work (4790)
BIOSECURE Act (2)
Biosimilars (65)
Biotechnology (24)
Bladder cancer (77)
Brain cancer (24)
Breast cancer (252)
Cancer (1804)
Cardiovascular disease (146)
Career advice (475)
Career pathing (6)
CAR-T (80)
CDC (4)
Cell therapy (250)
Cervical cancer (17)
Clinical research (30253)
Collaboration (566)
Company closure (2)
Compensation (404)
Complete response letters (5)
COVID-19 (929)
CRISPR (34)
C-suite (199)
Cystic fibrosis (53)
Data (2141)
Decentralized trials (1)
Denatured (4)
Depression (33)
Diabetes (168)
Diagnostics (2265)
Digital health (16)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (72)
Drug pricing (48)
Drug shortages (9)
Duchenne muscular dystrophy (79)
Earnings (50278)
Editorial (13)
Employer branding (7)
Employer resources (35)
Events (44161)
Executive appointments (450)
FDA (7370)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (5)
Funding (531)
Gene editing (66)
Generative AI (9)
Gene therapy (195)
GLP-1 (423)
Government (1352)
Grass and pollen (4)
Guidances (304)
Healthcare (6634)
HIV (24)
Huntington's disease (10)
IgA nephropathy (28)
Immunology and inflammation (78)
Immuno-oncology (4)
Indications (25)
Infectious disease (1025)
Inflammatory bowel disease (69)
Inflation Reduction Act (6)
Influenza (41)
Intellectual property (73)
Interviews (112)
IPO (8011)
IRA (15)
Job creations (1760)
Job search strategy (409)
Kidney cancer (7)
Labor market (26)
Layoffs (180)
Leadership (2)
Legal (2179)
Liver cancer (38)
Longevity (3)
Lung cancer (295)
Lymphoma (129)
Machine learning (9)
Management (12)
Manufacturing (208)
MASH (61)
Medical device (4805)
Medtech (4810)
Mergers & acquisitions (6811)
Metabolic disorders (429)
Multiple sclerosis (64)
NASH (10)
Neurodegenerative disease (66)
Neuropsychiatric disorders (16)
Neuroscience (958)
NextGen: Class of 2025 (2372)
Non-profit (1584)
Now hiring (10)
Obesity (204)
Opinion (65)
Ovarian cancer (57)
Pain (57)
Pancreatic cancer (66)
Parkinson's disease (104)
Partnered (9)
Patents (137)
Patient recruitment (116)
Peanut (19)
People (16238)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase I (8303)
Phase II (13288)
Phase III (11267)
Pipeline (1701)
Policy (52)
Postmarket research (1071)
Preclinical (2800)
Press Release (44)
Prostate cancer (92)
Psychedelics (10)
Radiopharmaceuticals (88)
Rare diseases (224)
Real estate (2125)
Recruiting (14)
Regulatory (7955)
Reports (21)
Research institute (683)
Resumes & cover letters (117)
Rett syndrome (9)
RNA editing (5)
RSV (28)
Schizophrenia (52)
Series A (75)
Series B (63)
Service/supplier (5)
Sickle cell disease (27)
Special edition (9)
Spinal muscular atrophy (64)
Sponsored (13)
Startups (1235)
Stomach cancer (3)
Supply chain (40)
Tariffs (28)
The Weekly (13)
Vaccines (341)
Venture capital (17)
Weight loss (139)
Women's health (18)
Worklife (3)
Date
Today (9)
Last 7 days (245)
Last 30 days (993)
Last 365 days (17371)
2025 (11883)
2024 (15104)
2023 (15017)
2022 (18874)
2021 (20133)
2020 (17970)
2019 (15532)
2018 (11807)
2017 (10742)
2016 (11550)
2015 (44338)
2014 (19409)
2013 (5929)
2012 (6496)
2011 (7322)
2010 (6287)
Location
Africa (369)
Alabama (24)
Alaska (3)
Arizona (68)
Arkansas (3)
Asia (16457)
Australia (2668)
California (4550)
Canada (1271)
China (352)
Colorado (181)
Connecticut (238)
Delaware (163)
Europe (39972)
Florida (550)
Georgia (120)
Hawaii (2)
Idaho (19)
Illinois (372)
India (20)
Indiana (226)
Iowa (8)
Japan (169)
Kansas (39)
Kentucky (12)
Louisiana (12)
Maine (32)
Maryland (512)
Massachusetts (3413)
Michigan (158)
Minnesota (220)
Mississippi (2)
Missouri (68)
Montana (11)
Nebraska (5)
Nevada (61)
New Hampshire (26)
New Jersey (1394)
New Mexico (5)
New York (1144)
North Carolina (519)
North Dakota (3)
Northern California (2057)
Ohio (111)
Oklahoma (6)
Oregon (14)
Pennsylvania (796)
Puerto Rico (2)
Rhode Island (7)
South America (470)
South Carolina (9)
Southern California (1715)
Tennessee (84)
Texas (706)
United States (16114)
Utah (130)
Virginia (106)
Washington D.C. (31)
Washington State (373)
West Virginia (3)
Wisconsin (63)
270,660 Results for "15".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
CSL Overhauls Business With Vaccine Spinout, 15% Layoffs
With its structural changes, CSL expects to generate $500 to $550 million in annualized savings over the next three years.
August 20, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025
September 10, 2025
·
1 min read
Press Releases
Actuate Therapeutics Announces Pricing of $15.0 Million Public Offering of Common Stock
September 11, 2025
·
3 min read
Tariffs
Trump Administration Settles on 15% Generic Drug Tariff Rate for EU
There’s still much more to come from the White House on tariffs, but the European Union has now reached a trade agreement with the U.S.
August 22, 2025
·
1 min read
·
Annalee Armstrong
Press Releases
Travere Therapeutics Presents Abstracts at the 15th International Congress of Inborn Errors of Metabolism
September 3, 2025
·
8 min read
Press Releases
Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split
August 15, 2025
·
5 min read
Press Releases
BioSig Technologies Inc. Announces Pricing of $15 Million Public Offering
August 13, 2025
·
4 min read
Press Releases
4DMT Announces New Employment Inducement Grants - August 15, 2025
August 18, 2025
·
2 min read
Press Releases
BioSig Technologies, Inc. & Streamex Announce Closing of $15 Million Public Offering
August 18, 2025
·
4 min read
Pain
Tonix Wins Approval For First New Fibromyalgia Drug in Over 15 Years
In Phase III studies, Tonmya showed significantly superior analgesic effects in patients with fibromyalgia versus placebo. The sublingual pill also led to better clinical outcomes.
August 18, 2025
·
1 min read
·
Tristan Manalac
1 of 27,066
Next
